A rapid practical RT-PCR-based approach for the detection of the PML/RARalpha fusion transcript in acute promyelocytic leukemia

American Journal of Clinical Pathology

Volumn 112, Issue 2, 1999, Pages 256-262

  Hussey, Charles E ^a   Lyon, Elaine ^a,b   Millson, Alison ^a   Lay, Marla J ^a   Wittwer, Carl T ^a,b   Segal, Glenn H ^c  

^a ARUP LABORATORIES   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c Dianon Systems   (United States)

Author keywords

Acute leukemia; Air thermal cycler; Chromosomal translocation t(15; 17); PML gene; RARalpha gene

Indexed keywords

RETINOIC ACID; RETINOIC ACID RECEPTOR;

ACUTE LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DIAGNOSTIC ACCURACY; DNA SEQUENCE; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033491254     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/112.2.256     Document Type: Article

References (24)

1. Stone RM, Mayer RJ. The unique aspects of acute promyelocytic leukemia. J Clin Oncol. 1990;8:1913-1921.
2. Degos L, Dombret H, Chomienne C, et al. All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood. 1995;85:2643-2653.
3. Grignani F, Fagioli M, Alcalay M, et al. Acute promyelocytic leukemia: from genetics to treatment. Blood. 1994;83:10-25.
4. - myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Blood. 1994;84:244-255.
5. Mancini M, Nanni M, Cedrone M, et al. Combined cytogenetic, FISH, and molecular analysis in acute promyelocytic leukaemia at diagnosis and in complete remission. Br J Haematol. 1995;91:878-884.
6. Miller WH, Kakizuka A, Frankel SR, et al. Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor α clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proc Natl Acad Sci U S A. 1992;89:2694-2698.
7. Miller WH, Levine K, DeBlasio A, et al. Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription-polymerase chain reaction assay for the PML/RARα fusion mRNA. Blood. 1993;82:1689-1694.
8. Lo Coco F, Diverio D, Pandolfi PP, et al. Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemia. Lancet. 1992;340:1437-1438.
9. Huang W, Sun G-L, Li X-S, et al. Acute promyelocytic leukemia: clinical relevance of two major PML/RARα isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse. Blood. 1993;82:1264-1269.
10. Fukatani H, Naoe T, Ohno R, et al. Prognostic significance of the RT-PCR assay of PML-RARA transcripts in acute promyelocytic leukemia. Leukemia. 1995;9:588-593.
11. Matsuoka A, Miyamura K, Emi N, et al. Unexpected heterogeneity of PML/RARα fused mRNA detected by nested polymerase chain reaction in acute promyelocytic leukemia. Leukemia. 1993;7:1151-1155.
12. Takatsuki H, Umemura T, Sadamura S, et al. Detection of minimal residual disease by reverse transcriptase polymerase chain reaction for the PML/RARα fusion mRNA: a study in patients with acute promyelocytic leukemia following peripheral stem cell transplantation. Leukemia. 1995;9:889-892.
13. Gallagher RE, Li Y-P, Rao S, et al. Characterization of acute promyelocytic leukemia cases with PML/RARα break/fusion sites in PML exon 6: identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acid. Blood. 1995;86:1540-1547.
14. Ikeda K, Sasaki K, Tasaka T, et al. Reverse transcription-polymerase chain reaction for PML/RARα fusion transcripts in acute promyelocytic leukemia and its application to minimal residual leukemia detection. Leukemia. 1993;7:544-548.
15. Castaigne S, Balitrand N, de Thé H, et al. A PML/retinoic acid receptor α fusion transcript is constantly detected by RNA-hased polymerase chain reaction in acute promyelocytic leukemia. Blood. 1992;79:3110-3115.
16. Biondi A, Rambaldi A, Pandolfi PR et al. Molecular monitoring of the myl/retinoic acid receptor-α fusion gene in acute promyelocytic leukemia by polymerase chain reaction. Blood. 1992;80:492-497.
17. Pandolfi PP, Alcalay M, Fagioli M, et al. Genomic variability and alternative splicing generate multiple PML/RARα transcripts that encode aberrant PML proteins and PML/RARα isoforms in acute promyelocytic leukemia. EMBO J. 1992;11:1397-1407.
18. Chen S-J, Chen Z, Chen A, et al. Occurrence of distinct PML/RARα fusion gene isoforms in patients with acute promyelocytic leukemia detected by reverse transcriptase/polymerase chain reaction. Oncogene. 1992;7:1223-1232.
19. Pandolfi PP, Grignani F, Alcalay M, et al. Structure and origin of the acute promyelocytic leukemia myl/RARα cDN A and characterization of its retinoic acid binding and transactivation properties. Oncogene. 1991;6:1285-1292.
20. Kakizuka A, Miller WH Jr, Umesono K, et al. Chromosomal translocation t(15;17) inhuman acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML.Cell. 1991;66:663-674.
21. Wittwer CT, Reed GB, Ririe KM. Rapid cycle DNA amplification. In: Mullis KB, Ferre F, Gibbs RA, eds. The Polymerase Chain Reaction. Boston, MA: Birkhauser, Boston; 1994:174-181.
22. Segal GH, Masih AS, Fox AC, et al. CD5-expressing B-cell non-Hodgkin's lymphomas with bcl-1 gene rearrangement have a relatively homogeneous immunophenotype and are associated with an overall poor prognosis. Blood. 1995;85:1570-1579.
23. Wittwer CT, Garling DJ. Rapid cycle DNA amplification: time and temperature optimization. Biotechniques. 1992;10:76-83.
24. Gallagher RE, Willman CL, Slack JL, et al. Association of PML-RARalpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular study. Blood. 1997;90:1656-1663.